Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
investing
3
×
life sciences
national blog main
cancer
clinical trials
deals
fda
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
startups
agios pharmaceuticals
alphabet
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
boulder/denver blog main
boulder/denver top stories
brexanolone
broad institute of harvard and mit
brook byers
camp4 therapeutics
cancer drugs
cancer immunotherapy
charles chu
crispr
crispr cas14
crispr therapeutics
crispr-cas9
david e. shaw
decheng capital
denali therapeutics
detroit blog main
What
today
3
×
ahead
ambien
american
annual
asco
attendees
attention
available
based
big
bio
biosciences
biotech
camp’s
cancer
cas
cash
cheaper
chicago
city
clinical
combinations
community’s
company’s
course
crispr
days
develop
development
diagnostics
discover
drug
expanding
expects
experimental
faster
focus
growing
handiwork
Language
unset
Current search:
today
×
" boston top stories "
×
investing
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More